Scientific evidence
Economic evaluation of implementing a novel pharmacogenomic test (IDgenetix®) to guide treatment of patients with depression and/or anxiety
Nov 2017
Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol
Mar 2017
Pharmacogenetics guidance resulted in frequent modifications of the analgesic program, resulting in excellent analgesia with a 50% reduction in narcotic consumption, and a reduced incidence of analgesic related side effects compared to our standard ERP.
Publication: The American Journal of Surgery
Contribution of pharmacogenetic testing to modeled medication change recommendations in a long-term care population with polypharmacy
Dec 2016
Among long-term care facility residents, polypharmacy is common, and often appropriate, given the need to treat multiple, complex, chronic conditions. Polypharmacy has, however, been associated with increased healthcare costs, adverse drug events, and drug interactions. The current study evaluates the potential medication cost savings of adding personalized pharmacogenetic information to traditional medication management strategies.
Publication: Drugs Aging